Loading
Latest filing published 15 Sept 2008 for Abraxis BioScience, Inc. (ABBI).
No signal scores available.
Thomas Silberg discloses dealings in Abraxis BioScience, Inc. (ABBI) to SEC (Form 4). In total, 2 filings cover trades dated from 12 December 2006 to 10 September 2008.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 15 September 2008, reports a transaction in Abraxis BioScience, Inc. (ABBI). Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations